Kite begins EU trial of CAR-T therapy

07:50 EDT 8 Aug 2017 | pharmaphorum

The first European patients are set to receive Kite Pharma’s CAR-T cancer therapy after the US biotech started EU trials. The first patient to receive the treatment known as axicabtagene ciloleucel in the expansion of the ZUMA-1 trial was treate...

Original Article: Kite begins EU trial of CAR-T therapy


More From BioPortfolio on "Kite begins EU trial of CAR-T therapy"

Quick Search

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...